ID   ERAP1_RAT               Reviewed;         930 AA.
AC   Q9JJ22; Q9JJ23;
DT   05-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   05-MAR-2002, sequence version 2.
DT   07-JAN-2015, entry version 110.
DE   RecName: Full=Endoplasmic reticulum aminopeptidase 1;
DE            EC=3.4.11.-;
DE   AltName: Full=ARTS-1;
DE   AltName: Full=Adipocyte-derived leucine aminopeptidase;
DE            Short=A-LAP;
DE   AltName: Full=Aminopeptidase PILS;
DE   AltName: Full=Puromycin-insensitive leucyl-specific aminopeptidase;
DE            Short=PILS-AP;
GN   Name=Erap1; Synonyms=Appils, Arts1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Pineal gland;
RX   PubMed=10824104; DOI=10.1046/j.1432-1327.2000.01348.x;
RA   Schomburg L., Kollmus H., Friedrichsen S., Bauer K.;
RT   "Molecular characterization of a puromycin-insensitive leucyl-specific
RT   aminopeptidase, PILS-AP.";
RL   Eur. J. Biochem. 267:3198-3207(2000).
CC   -!- FUNCTION: Aminopeptidase that plays a central role in peptide
CC       trimming, a step required for the generation of most HLA class I-
CC       binding peptides. Peptide trimming is essential to customize
CC       longer precursor peptides to fit them to the correct length
CC       required for presentation on MHC class I molecules. Strongly
CC       prefers substrates 9-16 residues long. Rapidly degrades 13-mer to
CC       a 9-mer and then stops. Preferentially hydrolyzes the residue Leu
CC       and peptides with a hydrophobic C-terminus, while it has weak
CC       activity toward peptides with charged C-terminus. May play a role
CC       in the inactivation of peptide hormones. May be involved in the
CC       regulation of blood pressure through the inactivation of
CC       angiotensin II and/or the generation of bradykinin in the kidney
CC       (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: Release of an N-terminal amino acid, Xaa-|-
CC       Xbb-, in which Xaa is preferably Leu, but may be other amino acids
CC       including Met, Cys and Phe.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Monomer. May also exist as a heterodimer; with ERAP2.
CC       Interacts with RBMX (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9JJ22-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9JJ22-2; Sequence=VSP_005451, VSP_005452;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10824104}.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase M1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF148323; AAF73106.1; -; mRNA.
DR   EMBL; AF148324; AAF73107.1; -; mRNA.
DR   RefSeq; NP_110463.1; NM_030836.1. [Q9JJ22-2]
DR   UniGene; Rn.22516; -.
DR   ProteinModelPortal; Q9JJ22; -.
DR   MINT; MINT-4568526; -.
DR   STRING; 10116.ENSRNOP00000013625; -.
DR   MEROPS; M01.018; -.
DR   PhosphoSite; Q9JJ22; -.
DR   PaxDb; Q9JJ22; -.
DR   PRIDE; Q9JJ22; -.
DR   GeneID; 80897; -.
DR   KEGG; rno:80897; -.
DR   UCSC; RGD:708542; rat. [Q9JJ22-1]
DR   CTD; 51752; -.
DR   RGD; 708542; Erap1.
DR   eggNOG; COG0308; -.
DR   HOGENOM; HOG000106482; -.
DR   HOVERGEN; HBG108296; -.
DR   InParanoid; Q9JJ22; -.
DR   KO; K09604; -.
DR   PhylomeDB; Q9JJ22; -.
DR   NextBio; 614912; -.
DR   PRO; PR:Q9JJ22; -.
DR   Proteomes; UP000002494; Unplaced.
DR   Genevestigator; Q9JJ22; -.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IDA:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:RGD.
DR   GO; GO:0004177; F:aminopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0005138; F:interleukin-6 receptor binding; ISS:UniProtKB.
DR   GO; GO:0008235; F:metalloexopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0005164; F:tumor necrosis factor receptor binding; IPI:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IMP:RGD.
DR   GO; GO:0019882; P:antigen processing and presentation; TAS:RGD.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; ISS:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IMP:RGD.
DR   InterPro; IPR024571; ERAP1-like_C_dom.
DR   InterPro; IPR001930; Peptidase_M1.
DR   InterPro; IPR014782; Peptidase_M1_N.
DR   PANTHER; PTHR11533; PTHR11533; 1.
DR   Pfam; PF11838; ERAP1_C; 1.
DR   Pfam; PF01433; Peptidase_M1; 1.
DR   PRINTS; PR00756; ALADIPTASE.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   2: Evidence at transcript level;
KW   Adaptive immunity; Alternative splicing; Aminopeptidase;
KW   Complete proteome; Disulfide bond; Endoplasmic reticulum;
KW   Glycoprotein; Hydrolase; Immunity; Membrane; Metal-binding;
KW   Metalloprotease; Protease; Reference proteome; Signal-anchor;
KW   Transmembrane; Transmembrane helix; Zinc.
FT   CHAIN         1    930       Endoplasmic reticulum aminopeptidase 1.
FT                                /FTId=PRO_0000026753.
FT   TOPO_DOM      1      2       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      3     23       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     24    930       Lumenal. {ECO:0000255}.
FT   REGION      306    310       Substrate binding. {ECO:0000250}.
FT   ACT_SITE    343    343       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10095}.
FT   METAL       342    342       Zinc; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10095}.
FT   METAL       346    346       Zinc; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10095}.
FT   METAL       365    365       Zinc; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10095}.
FT   BINDING     172    172       Substrate. {ECO:0000250}.
FT   SITE        427    427       Transition state stabilizer.
FT                                {ECO:0000250}.
FT   CARBOHYD     59     59       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    143    143       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    403    403       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    655    655       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    749    749       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    890    890       N-linked (GlcNAc...). {ECO:0000255}.
FT   DISULFID    393    432       {ECO:0000250}.
FT   DISULFID    725    732       {ECO:0000250}.
FT   VAR_SEQ     883    884       FF -> CM (in isoform 2).
FT                                {ECO:0000303|PubMed:10824104}.
FT                                /FTId=VSP_005451.
FT   VAR_SEQ     885    930       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10824104}.
FT                                /FTId=VSP_005452.
SQ   SEQUENCE   930 AA;  106419 MW;  928E7143CBD0EE7F CRC64;
     MPSLLSLVLT FLAVSSPSCC QNSDTASPKA SNGASFPWNN MRLPEYITPI HYDLMIHANL
     STLTFWGKTE VEITVSQPTS TIIMHSHQLQ ISKATLRRGA EEMLPEEPLK LMEYSAHEQV
     ALLTAQPLLA GSVYTVIITY AANLSENFHG FYKSTYRTQE GERRILAATQ FEPTAARMAF
     PCFDEPALKA SFSIKIKRDP RHLAISNMPL VKSVTVAEGL IEDHFDITVK MSTYLVAFII
     SDFKSVSKMT KSGVKVSVYA VPDKINQADY ALDAAVTLLE FYEDYFSIPY PLPKQDLAAI
     PDFQSGAMEN WGLTTYRESA LLYDKEKSSA SSKLGITMTV SHELAHQWFG NLVTMEWWND
     LWLNEGFAKF MEFVSVTVTH PELKVEEYFF GKCFNAMEVD ALNSSHPVST PVENPAQIRE
     MFDEVSYEKG ACILNMLRDY LSADTFKRGI VQYLQKYSYK NTKNEDLWNS MMHICPTDGT
     QTMDGFCSRN QHSSSTSHWR QEVIDIKSMM NTWTLQKGFP LITITVRGRN VHLKQEHYMK
     GSECFPETGS LWHVPLTFIT SKSDSVQRFL LKTKTDVIIL PEAVEWIKFN VGMNGYYIVH
     YGDDGWASLN GLLKEAHTTI SSNDRASLIN NAFQLVSIGK LSIEKALDLI LYLKNETEIM
     PIFQGLNELI PMYKLMEKRD MVEVETQFKD FLLRLLKDLI NKQTWTDEGS VSERMLRSQL
     LLLACVHRYQ LCVQRAERYF REWKASNGNM SLPIDVTLAV FAVGAQNTEG WDFLYSKYQS
     SLSSTEKSQI EFSLCISQDP EKLQWLLDQS FKGEIIKTQE FPHILTLIGR NPVGYPLAWK
     FLKENWNKIV QKFELGSSSI AHMVMGTTNQ FSTRARLEEV KGFFSSLKKN GSQLRCVQQT
     IETIEENIRW MDKNFDKIRL WLQKERQELL
//
